Guardant Health
GH
#1738
Rank
ยฃ8.66 B
Marketcap
ยฃ66.04
Share price
1.76%
Change (1 day)
85.52%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of December 2025 : ยฃ1.50 Billion

According to Guardant Health 's latest financial reports the company's total assets are ยฃ1.50 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2025-12-31ยฃ1.49 B26.3%
2024-12-31ยฃ1.18 B-15.57%
2023-12-31ยฃ1.40 B5.37%
2022-12-31ยฃ1.33 B-18.51%
2021-12-31ยฃ1.63 B-2.01%
2020-12-31ยฃ1.66 B127.06%
2019-12-31ยฃ0.73 B58.62%
2018-12-31ยฃ0.46 B82.37%
2017-12-31ยฃ0.25 B168.6%
2016-12-31ยฃ94.46 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Neogen
NEOG
ยฃ2.51 B 66.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
ยฃ1.79 B 19.10%๐Ÿ‡บ๐Ÿ‡ธ USA